ALX Oncology Holdings Inc.
USD1.92
-0.18 (-8.57%)
CEO
Jason Lettmann
IPO Date
2020-07-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.12
Prev. Close
$2.10
Day Low
$1.91
Day High
$2.13
52W Low
$0.44
52W High
$2.66
Market Cap
$0.26B
Volume
0.49M
| 800,000 |
| $1.68 |
| 17 Apr 2026 | Klencke Barbara | Chief Medical Officer | A-Award | Acquired | 100,000 | $1.68 |
| 17 Apr 2026 | Knight Jeff E. | — | Disposed | 0 | $0.00 |
| 23 Mar 2026 | Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 12,311 | $2.17 |
| 23 Mar 2026 | Pinto Shelly | SVP, FINANCE AND CAO | S-Sale | Disposed | 903 | $2.17 |
| 5 Mar 2026 | Klencke Barbara | Chief Medical Officer | A-Award | Acquired | 700,000 | $2.07 |
| 5 Mar 2026 | Klencke Barbara | Chief Medical Officer | Disposed | 0 | $0.00 |
| 5 Mar 2026 | Klencke Barbara | Chief Medical Officer | Disposed | 40,400 | $1.65 |
| 5 Mar 2026 | Klencke Barbara | Chief Medical Officer | Disposed | 300,000 | $1.05 |